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Background
Infantile Cushing syndrome is rare. We report an
8 month-old infant who developed growth failure and
hypertension from an apparently innocuous topical ster-
oid application.
Case Presentation
An 8 month-old boy was referred to the endocrinology
clinic for concerns of growth failure since 3 months of
age. He was born full term with a birth weight of 2.67kg
and a length of 45cm. His parents noticed that he was
not growing well from 3 months of age. However, his
weight gain remained more than satisfactory and he
gained 700g in the past month. This infant was other-
wise in good health, apart from atopic dermatitis, for
which the parents had been applying a daily cream with
good effect. He was breast fed until 2 months of age
and weaned onto solids at 6 months of age.
On examination, the infant had a moon face with hyper-
trichosis, facial telangiectasia and prominent supraclavicu-
lar fat pads. His recumbent length was 62cm (<3rd
percentile), his weight was 7.74 kg (25th percentile), and
his head circumference was 41.0 cm (3rd percentile).
There was no hyperpigmentation or lentigenes, but he was
hypertensive with a blood pressure of 140/90 mmHg (95th
percentile for age is 99/55 mm Hg) with a heart rate of
140 beats/minute. His apex beat was not displaced and his
heart sounds were normal with no murmurs.
A random steroid profile demonstrated a depressed
serum cortisol level of 30 nmol/L and an unmeasurably
low serum ACTH level of <1.1 pmol/L. This was consis-
tent with exogenous Cushing syndrome. An ECG showed
biventricular hypertrophy and a 2-D echocardiogram
confirmed severe biventricular hypertrophy with good
ventricular function.
On further questioning, he had been receiving twice
daily applications of a topical cream for atopic dermati-
tis, which had been obtained over the counter, without
a prescription. Subsequent analysis of the topical agent
revealed the contents to be betametasone dipropionate,
a high potency corticosteroid.
On establishing the diagnosis of exogenous Cushing syn-
drome, the offending topical steroid cream was discontin-
ued. Since he was at risk of primary adrenal failure from
sudden withdrawal of steroid cream, he was started on a
weaning regimen of hydrocortisone. He was also com-
menced on captopril which achieved good blood pressure
control.
Conclusion
Continuous use of high potency topical corticosteroids
over several months can lead to Cushing syndrome.
Physiologic dosing of hydrocortisone should be pre-
scribed to prevent an adrenal crisis until hypothalamic-
pituitary-adrenal axis recovery is confirmed.
Written informed consent was obtained from the
patient for publication of this abstract and any accom-
panying images. A copy of the written consent is avail-
able for review by the Editor of this journal.
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